Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of donepezil and folic acid is used as an adjunctive treatment for Alzheimer's disease. Donepezil is an acetylcholinesterase inhibitor that helps improve cognitive function in patients with Alzheimer's disease[4][5]. Folic acid supplementation has been shown to mitigate Alzheimer's disease by reducing inflammation and may provide additional benefits when combined with donepezil[2]. ## Mechanism and Efficacy Donepezil works by inhibiting acetylcholinesterase, which increases acetylcholine levels in the brain. This helps improve cognitive function in patients with mild, moderate, and severe Alzheimer's disease[4][5]. Folic acid supplementation helps reduce inflammation and homocysteine levels, which have been linked to Alzheimer's disease progression[2]. Studies have shown that the combination of donepezil with folic acid can lead to: - Improved Mini-Mental State Examination (MMSE) scores compared to donepezil alone[2] - Reduced levels of inflammatory markers like TNFα[2] - Altered amyloid beta ratios, potentially affecting disease progression[2] - Increased S-adenosylmethionine (SAM) levels and SAM/SAH ratio[2] In one study, patients receiving donepezil plus folic acid supplementation for 6 months showed significant improvements in cognitive function compared to those receiving donepezil alone[2]. ## Safety and Side Effects The combination therapy is generally well-tolerated. Common side effects associated with donepezil include: - Nausea - Insomnia - Diarrhea - Mild changes in heart rate[5] These side effects are typically mild and transient. No significant additional adverse effects have been reported when combining donepezil with folic acid supplementation[2][5]. ## Clinical Considerations When considering this combination therapy, healthcare providers should be aware of potential drug interactions. Donepezil may interact with: - Heart medications (amiodarone, atenolol, bisoprolol, digoxin, verapamil) - Epilepsy medications (phenytoin, carbamazepine) - NSAIDs (aspirin, ibuprofen) - Mental health medications (risperidone, olanzapine, fluoxetine) - Certain antibiotics (erythromycin, rifampicin) - St. John's wort (which can lower donepezil levels)[3] The combination of donepezil with folic acid appears to be a promising approach for enhancing the treatment of Alzheimer's disease, particularly by addressing both cholinergic dysfunction and inflammatory processes involved in the disease pathology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Donepezil and Folic Acid Combination.